Sigma-Aldrich Corporation's new facility will support commercial-scale gene therapy production,...
Pharmaceutical processors face a number of challenges in determining the direction they should...
Sigma-Aldrich Corporation today announced that SAFC Commercial, its custom manufacturing services business unit, has introduced ADC Express preclinical development services.
NeoStem, Inc., a biopharmaceutical company developing novel cell-based individualized medicine therapies, announced today the expansion of manufacturing services under an existing Services Agreement between its wholly-owned subsidiary, PCT, and Kite Pharma.
Sartorius Stedim Biotech (SSB), an international supplier for the biopharmaceutical industries, today acquired the Scottish company BioOutsource Ltd.
International Pharmaceutical Expo, the premier industry event dedicated to showcasing pharmaceutical and biopharmaceutical innovation, technology and knowledge, today announced ACG North America will feature their line of end-to-end oral solid dosage manufacturing, packaging and inspection technologies, at INTERPHEX 2015.
The May issue of Pharmaceutical Processing profiles PCI, a contract developer and manufacturer of custom NCEs, fine chemicals and generic APIs based in Newburyport, MA. We also take a look at the critical success factors clients evaluate when choosing a CMO. Our manufacturing services Q&A discusses current trends, issues and the future of pharmaceutical processing services. In addition we cover tablet coating, single-use technologies and QbD in test method development and validation.
Truven Health Analytics, formerly the Healthcare business of Thomson Reuters, today announced that the Truven Health Advantage Suite™ healthcare data and analytics platform version 5 has achieved Oracle Exadata Ready status through Oracle PartnerNetwork (OPN).
With three cGMP compliant facilities located in New England, the company has been providing lyophilization services to the pharmaceutical, biotechnology and medical device industries since 1997.
The company has expanded its services for solid-dose potent and cytotoxic products in response to robust market demand.